Home Newsfeeds HC Wainwright & Co. Downgrades SQZ Biotechnologies to Neutral

HC Wainwright & Co. Downgrades SQZ Biotechnologies to Neutral

HC Wainwright & Co. analyst Emily Bodnar downgrades SQZ Biotechnologies (NYSE:SQZ) from Buy to Neutral.

byBenzinga Newsdesk

December 2, 2022

1 minute read

HC Wainwright & Co. analyst Emily Bodnar downgrades SQZ Biotechnologies (NYSE:SQZ) from Buy to Neutral.

Recap Of Wednesday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 10, 6:23 PM

Bristol Myers Squibb (NYSE:BMY) and 2seventy bio (NASDAQ:TSVT) announced positive topline results from KarMMa-3, a Phase 3 study…

BBIO

What’s Going On With Disney Stock Wednesday?

By Anusuya Lahiri

November 15, 10:52 AM

Walt Disney Co (NYSE: DIS) stock is trading higher Wednesday as reports indicate activist investor ValueAct has been building a stake in the company.

CRM

Cronos Cannabis Company Slashes Losses, Reports Highest Quarterly Net Revenue In Q1 2024

By Nicolas Jose Rodriguez

May 9, 1:18 PM

Cronos Group Inc., (NASDAQ: CRON) a global cannabinoid company, has reported an increase in net revenue for the first quarter of 2024.

CRON

EXCLUSIVE: VERSES, DENTONS US and Spatial Web Foundation Collaborate Over AI Industry Report

By Anusuya Lahiri

July 24, 7:45 AM

VERSES AI Inc (OTC: VRSSF), a cognitive computing company specializing in the next generation of artificial intelligence, today announced the release of a landmark AI industry report, "The Future of Global AI Governance."

VRSSF

HC Wainwright & Co. Downgrades SQZ Biotechnologies to Neutral

Related Posts

Recap Of Wednesday’s Biotech Catalysts – End Of the Day Summary

What’s Going On With Disney Stock Wednesday?

Cronos Cannabis Company Slashes Losses, Reports Highest Quarterly Net Revenue In Q1 2024

EXCLUSIVE: VERSES, DENTONS US and Spatial Web Foundation Collaborate Over AI Industry Report